Top stocks in focus: Lupin, Zydus Wellness, Coal India, REC, PFC

Lupin’s Canada arm received an approval from Health Canada for Zaxine drug used for the treatment of irritable bowel syndrome.

Cabinet approves sale of govt’s 52.6% stake in REC to PFC for Rs15,000cr.

Zydus Wellness to raise funds by issuing preference shares worth Rs2,575cr to Cadila Healthcare, Zydus Family Trust, Pioneer Investment Fund and True North Fund.

Government cuts stake in Coal India by 2.2% to 72.9%.

HUDCO Board mulls raising up to Rs1,000cr via bonds.

HCL Technologies to buy select IBM software products for $1.8 billion.

Reliance Industries’ Reliance Jio Infocomm board was considering restructuring and reorganizing proposals on Dec 11.

Majesco to invest ~$35mn in US unit’s right offering to fund remainder of Exaxe acquisition, pay off debt, and accelerate crowd solution growth.

MPS received intimation from ADI BPO Services for withdrawal of scheme of amalgamation of the latter company with MPS. 

Wipro’s digital business arm announced expanded global partnership with the U.S. based ‘Alfresco’ to offer open source digital solutions.